The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):


	Three Months Ended
	September 27, 2025		September 28, 2024
Numerator:
Net income (loss) - basic and diluted	$	4.2	$	(82.4)

Denominator:
Weighted average common shares outstanding - basic	70.3		68.3
Effect of dilutive securities from ESPP	0.1		—
Effect of dilutive securities from stock options	0.4
Effect of dilutive securities from RSUs and PSUs	1.9		—
Shares issuable assuming conversion of the convertible notes	5.6		—
Weighted average common shares outstanding - diluted	78.3		68.3

Net income (loss) per share:
Basic	$	0.06	$	(1.21)
Diluted	$	0.05	$	(1.21)

Potentially dilutive common shares result from the assumed exercise of outstanding stock options, assumed vesting of equity awards, and assumed issuance of stock under the ESPP, all using the treasury stock method.

Potentially dilutive common shares issuable upon conversion of our outstanding convertible notes are determined using the if-converted method.

There were no anti-dilutive shares excluded from the calculation of diluted net income per share during the three months ended September 27, 2025. Anti-dilutive shares excluded from the calculation of diluted net loss per share for the three months ended September 28, 2024 include 4.8 million shares issuable under restricted stock units (“RSUs”) and performance stock units (“PSUs”), 0.1 million shares issuable under the Employee Stock Purchase Plan (the “ESPP”), and 1.0 million shares outstanding related to stock options. Refer to “Note 12. Equity.